目的:探讨甲状腺素/游离三碘甲状腺原氨酸(free thyroxine/free triiodothyronine, FT4/FT3)与急性冠脉综合征(acute coronary syndrome, ACS)患者接受经皮冠状动脉介入(percutaneous coronary intervention, PCI)治疗后发生支架内再狭...目的:探讨甲状腺素/游离三碘甲状腺原氨酸(free thyroxine/free triiodothyronine, FT4/FT3)与急性冠脉综合征(acute coronary syndrome, ACS)患者接受经皮冠状动脉介入(percutaneous coronary intervention, PCI)治疗后发生支架内再狭窄(in-stent restenosis, ISR)的相关性,为ACS患者PCI术后出现支架内再狭窄提供一定的参考。方法:回顾性分析于济宁医学院附属医院行冠状动脉支架置入术,并于2021年1月至2022年12月来院复查造影的476例患者的临床资料,根据复查冠脉造影结果将其分为ISR组257例和非ISR组219例。比较两组患者基础资料,通过多因素Logistic回归分析明确冠心病患者发生ISR的影响因素,采用受试者工作特征(ROC)曲线分析FT4/FT3对冠脉支架置入后患者发生ISR的预测价值。结果:ISR组中高血压的患者比例、LDL、FT4/FT3水平高于非ISR组(P Objective: To investigate the correlation between thyroxine/free triiodothyronine (FT4/FT3) and in-stent restenosis (ISR) after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). The correlation between PCI and ISR in patients with ACS was analyzed to provide a reference for the occurrence of in-stent restenosis in ACS patients after PCI. Methods: We retrospectively analyzed the clinical data of 476 patients who underwent coronary stenting at the Affiliated Hospital of Jining Medical College and came to the hospital for follow-up angiography from January 2021 to December 2022, and classified them into 257 cases in the ISR group and 219 cases in the non-ISR group according to the results of follow-up coronary angiography. Comparing the basic data of patients in the two groups, we clarified the influencing factors for the occurrence of ISR in patients with coronary artery disease by multifactorial Logistic regression analysis, and analyzed the predictive value of FT4/FT3 for the occurrence of ISR in patients after coronary stent placement by using the subject's work characteristics (ROC) curve. Results: The proportion of patients with hypertension, LDL, and FT4/FT3 levels were higher in the ISR group than in the non-ISR group (P < 0.05), whereas FT3, FT4, LVEF values, and stent diameters were lower in the ISR group than in the non-ISR group (P < 0.05);multifactorial Logistic regression analysis confirmed that FT4/FT3, LDL, and stent diameters were independent risk factors;after correcting for various confounders using multifactorial Logistic regression analysis in the prediction model, the results showed that FT4/FT3 was independently associated with ISR. ROC analysis confirmed that FT4/FT3 predicted ISR with an AUC of 0.703 (95% CI: 0.652~0.751, P < 0.05), a sensitivity of 0.792, and a specificity of 0.558. Conclusions: FT4/FT3, LDL, and stent diameter were the independent risk factors for post-PCI in-stent restenosis;FT4/FT3 alone predicted the risk of in-stent restenosis after PCI.展开更多
【目的】分析28~36周早产儿生后3~21 d FT3、FT4、TSH变化的特征。【方法】回顾性分析2018年7月至2019年6月中山大学附属第三医院新生儿科住院的236例28~36周早产儿的临床资料,包括甲状腺功能检查(FT3、FT4和TSH)、胎龄、性别、出生体...【目的】分析28~36周早产儿生后3~21 d FT3、FT4、TSH变化的特征。【方法】回顾性分析2018年7月至2019年6月中山大学附属第三医院新生儿科住院的236例28~36周早产儿的临床资料,包括甲状腺功能检查(FT3、FT4和TSH)、胎龄、性别、出生体质量、出生身长、检查日龄、辅助生殖方式、单胎或多胎、母亲甲状腺疾病和母亲妊娠期糖尿病,比较早产儿3~7 d与8~21 d FT3、FT4和TSH水平的差异;分析影响早产儿FT3、FT4和TSH水平的独立因素;比较不同胎龄早产儿FT3、FT4和TSH水平差异。【结果】早产儿3~7 d FT3水平(3.23±0.54)pmol/L,低于8~21 d的(3.41±0.76)pmol/L,差异有统计学意义(P=0.040);早产儿3~7 d的FT4水平(15.36±3.40)pmol/L,高于8~21 d的(13.20±2.63)pmol/L,差异有统计学意义(P<0.001);3~7 d与8~21 d的TSH分布的差异没有统计学意义(P=0.846);早产儿3~7 d FT3水平受到胎龄的影响(P<0.001),3~7天FT4水平受到胎龄和检查日龄的影响(P<0.001),8~21 d的FT3、FT4水平均受到胎龄和性别的影响(P<0.001、P<0.001);3~7 d、8~21 d的FT3、FT4水平与胎龄为正相关(P<0.001,P<0.001;P<0.001,P=0.001)。【结论】胎龄影响生后3~21 d早产儿的甲状腺功能,胎龄越小,FT3、FT4越低,需要建立一个胎龄相关的的FT4或T4参考范围,结合TSH联合评估甲状腺功能。展开更多
文摘目的:探讨甲状腺素/游离三碘甲状腺原氨酸(free thyroxine/free triiodothyronine, FT4/FT3)与急性冠脉综合征(acute coronary syndrome, ACS)患者接受经皮冠状动脉介入(percutaneous coronary intervention, PCI)治疗后发生支架内再狭窄(in-stent restenosis, ISR)的相关性,为ACS患者PCI术后出现支架内再狭窄提供一定的参考。方法:回顾性分析于济宁医学院附属医院行冠状动脉支架置入术,并于2021年1月至2022年12月来院复查造影的476例患者的临床资料,根据复查冠脉造影结果将其分为ISR组257例和非ISR组219例。比较两组患者基础资料,通过多因素Logistic回归分析明确冠心病患者发生ISR的影响因素,采用受试者工作特征(ROC)曲线分析FT4/FT3对冠脉支架置入后患者发生ISR的预测价值。结果:ISR组中高血压的患者比例、LDL、FT4/FT3水平高于非ISR组(P Objective: To investigate the correlation between thyroxine/free triiodothyronine (FT4/FT3) and in-stent restenosis (ISR) after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). The correlation between PCI and ISR in patients with ACS was analyzed to provide a reference for the occurrence of in-stent restenosis in ACS patients after PCI. Methods: We retrospectively analyzed the clinical data of 476 patients who underwent coronary stenting at the Affiliated Hospital of Jining Medical College and came to the hospital for follow-up angiography from January 2021 to December 2022, and classified them into 257 cases in the ISR group and 219 cases in the non-ISR group according to the results of follow-up coronary angiography. Comparing the basic data of patients in the two groups, we clarified the influencing factors for the occurrence of ISR in patients with coronary artery disease by multifactorial Logistic regression analysis, and analyzed the predictive value of FT4/FT3 for the occurrence of ISR in patients after coronary stent placement by using the subject's work characteristics (ROC) curve. Results: The proportion of patients with hypertension, LDL, and FT4/FT3 levels were higher in the ISR group than in the non-ISR group (P < 0.05), whereas FT3, FT4, LVEF values, and stent diameters were lower in the ISR group than in the non-ISR group (P < 0.05);multifactorial Logistic regression analysis confirmed that FT4/FT3, LDL, and stent diameters were independent risk factors;after correcting for various confounders using multifactorial Logistic regression analysis in the prediction model, the results showed that FT4/FT3 was independently associated with ISR. ROC analysis confirmed that FT4/FT3 predicted ISR with an AUC of 0.703 (95% CI: 0.652~0.751, P < 0.05), a sensitivity of 0.792, and a specificity of 0.558. Conclusions: FT4/FT3, LDL, and stent diameter were the independent risk factors for post-PCI in-stent restenosis;FT4/FT3 alone predicted the risk of in-stent restenosis after PCI.
文摘【目的】分析28~36周早产儿生后3~21 d FT3、FT4、TSH变化的特征。【方法】回顾性分析2018年7月至2019年6月中山大学附属第三医院新生儿科住院的236例28~36周早产儿的临床资料,包括甲状腺功能检查(FT3、FT4和TSH)、胎龄、性别、出生体质量、出生身长、检查日龄、辅助生殖方式、单胎或多胎、母亲甲状腺疾病和母亲妊娠期糖尿病,比较早产儿3~7 d与8~21 d FT3、FT4和TSH水平的差异;分析影响早产儿FT3、FT4和TSH水平的独立因素;比较不同胎龄早产儿FT3、FT4和TSH水平差异。【结果】早产儿3~7 d FT3水平(3.23±0.54)pmol/L,低于8~21 d的(3.41±0.76)pmol/L,差异有统计学意义(P=0.040);早产儿3~7 d的FT4水平(15.36±3.40)pmol/L,高于8~21 d的(13.20±2.63)pmol/L,差异有统计学意义(P<0.001);3~7 d与8~21 d的TSH分布的差异没有统计学意义(P=0.846);早产儿3~7 d FT3水平受到胎龄的影响(P<0.001),3~7天FT4水平受到胎龄和检查日龄的影响(P<0.001),8~21 d的FT3、FT4水平均受到胎龄和性别的影响(P<0.001、P<0.001);3~7 d、8~21 d的FT3、FT4水平与胎龄为正相关(P<0.001,P<0.001;P<0.001,P=0.001)。【结论】胎龄影响生后3~21 d早产儿的甲状腺功能,胎龄越小,FT3、FT4越低,需要建立一个胎龄相关的的FT4或T4参考范围,结合TSH联合评估甲状腺功能。
